Elsie Biotechnologies Inc.

ELSIE BIOTECHNOLOGIES

Custom manufacture of oligonucleotides;Oligonucleotide compounds for use in pharmaceutical therapies; Oligonucleotide delivery agents for use in pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals; Pharmaceuticals comprised of oligonucleotide compounds; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; drug delivery agents consisting of oligonucleotide compounds;Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds;

X

Custom manufacture of oligonucleotides;The mark consists of a series of short horizontal lines formed into the shape of an X, superimposed on and largely within a diamond shape with rounded corners.;Oligonucleotide compounds for use in pharmaceutical therapies; Oligonucleotide delivery agents for use in pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals; Pharmaceuticals comprised of oligonucleotide compounds; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; drug delivery agents consisting of oligonucleotide compounds;Color is not claimed as a feature of the mark.;Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds;